Digest Network Come funziona
Network
/
Società
Pe
Non verificato

Personalis, Inc.

Di cosa scriviamo

BiotecnologiaFarmaceuticaMedicina - VarieOncologiaSalute

69 comunicati stampa

Guarda tutti i comunicati
20/07/2026
Mercato azionario
Web e Social Network
Tecnica
Biotecnologia
Medicina - Varie
Sanità
Farmaceutica
Salute
Oncologia
Tempus to Acquire Personalis, More Tightly Integrating Molecular Residual Disease (MRD) into Its AI-Enabled Precision Oncology Platform
Fonte
Personalis, Inc.
Emittente
Business Wire
1.00
0
14/07/2026
Industria
Oncologia
Salute
Biotecnologia
Medicina - Varie
Farmaceutica
Personalis Accelerates Global Expansion with UKCA Marking for NeXT Personal®, Expanding MRD Access and Biopharma Support in Great Britain
Fonte
Personalis, Inc.
Emittente
Business Wire
1.00
0
09/06/2026
Industria
Oncologia
Salute
Biotecnologia
Medicina - Varie
Farmaceutica
Personalis Enables Global Biopharma Support with CE-IVD Marked Specimen Collection Kits
Fonte
Personalis, Inc.
Emittente
Business Wire
1.00
0
02/06/2026
Oncologia
Salute
Sanità
Medicina - Varie
Biotecnologia
Eventi
Fiere
Industria
Personalis Highlights Early Colorectal Cancer Recurrence Detection and Ultrasensitive MRD Performance Across a Broad Set of Tumor Types at ASCO 2026
Fonte
Personalis, Inc.
Emittente
Business Wire
1.00
0
26/05/2026
Eventi
Industria
Oncologia
Salute
Medicina - Varie
Scienza
Farmaceutica
Biotecnologia
Personalis to Highlight Breadth of NeXT Personal® Ultra-Sensitive ctDNA Data at ASCO 2026 Annual Meeting, Including Podium Presentation from TRACERx Consortium
Fonte
Personalis, Inc.
Emittente
Business Wire
1.00
0
20/05/2026
Industria
Biotecnologia
Salute
Oncologia
Scienza
Medicina - Varie
Vetrine/Shopping
Personalis Secures Fourth Medicare Coverage Decision for NeXT Personal®, Expanding Breast Cancer Coverage to Pre-Surgical Treatment Monitoring
Fonte
Personalis, Inc.
Emittente
Business Wire
1.00
0
14/05/2026
Eventi
Web e Social Network
Oncologia
Salute
Biotecnologia
Medicina - Varie
Farmaceutica
Personalis to Participate in Upcoming Investor Events
Fonte
Personalis, Inc.
Emittente
Business Wire
1.00
0
13/05/2026
Industria
Biotecnologia
Medicina - Varie
Salute
Farmaceutica
Sanità
Oncologia
Personalis Receives Medicare Coverage for NeXT Personal® for Immunotherapy Monitoring Across Late-stage Solid Tumors
Fonte
Personalis, Inc.
Emittente
Business Wire
1.00
0
07/05/2026
Mercato azionario
Oncologia
Salute
Biotecnologia
Medicina - Varie
Farmaceutica
Personalis Reports First Quarter Results and Recent Highlights
Fonte
Personalis, Inc.
Emittente
Business Wire
1.00
0
23/04/2026
Web e Social Network
Telefonia e Varie
Finanza
Mercato azionario
Oncologia
Salute
Biotecnologia
Medicina - Varie
Farmaceutica
Personalis to Announce First Quarter 2026 Financial Results
Fonte
Personalis, Inc.
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0